Drug Topics

JUNE 5, 2023

Patients were more likely to require ICU admission.

Hospitals 469

Hospitals 469

PharmaVoice

JUNE 5, 2023

Rachel King took the reins at BIO during a rocky time. Now, after steadying the ship, she’s brought the trade association’s focus back to the industry’s most pressing priorities.

245

245

Drug Topics

JUNE 5, 2023

Mandy Cohen is set to become the next CDC director, Medicare will cover a new class of Alzheimer’s drugs, and the WHO announces a landmark digital health initiative.

247

247

Pharmacy Times

JUNE 5, 2023

It’s imperative to redefine the future of pharmacy to help ensure a robust pipeline of future pharmacists and create a culture that helps ensure pharmacists live their purpose and passion.

Community Pharmacies 172

Community Pharmacies 172

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Fierce Healthcare

JUNE 5, 2023

The roughly half of American smartphone users with iPhones will notice new health and pri | Apple brings its Health app to the iPad while offering new vision and mental health features to its suite of devices.

137

137

Pharmacy Times

JUNE 5, 2023

Treatment with Injectafer significantly improved exercise capacity compared to placebo in a randomized clinical trial in adult patients with heart failure.

FDA 132

FDA 132

Fierce Healthcare

JUNE 5, 2023

Self-insured employers face myriad challenges in trying to manage growing healthcare costs, and one of those results from recent history, according to a

Insurance 129

Insurance 129

PharmaVoice

JUNE 5, 2023

A partnership going on six years between the pharma giant and the Chinese biotech is showing that their CAR-T cell therapy for multiple myeloma is highly effective.

130

130

STAT

JUNE 5, 2023

The Food and Drug Administration has removed a neurologist with financial ties to Biogen and Eisai — which jointly develop and market a pair of controversial Alzheimer’s drugs — from an upcoming advisory panel meeting to review one of those treatments. David Weisman was cleared two months ago by the agency as a temporary voting member of an advisory committee that will meet Friday to consider whether a drug called lecanemab, which is promoted by the companies, should be full

FDA 124

FDA 124

Fierce Healthcare

JUNE 5, 2023

The home health bidding wars are heating up as UnitedHealth Group's Optum unit is making a big play for home health and hospice firm Amedisys. |.Just one month ago, Amedisys agreed to be bought by another healthcare company, Option Care Health, a provider of post-acute care and infusion services.

123

123

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JUNE 5, 2023

Research notes that modifiable lifestyle factors, such as overconsumption of food and vitamin deficiency, can affect pregnancy.

123

123

STAT

JUNE 5, 2023

SAN FRANCISCO — Primary care tech startup Carbon Health is using artificial intelligence to listen in on patient appointments and automatically write up near-complete notes within minutes, directly in its own electronic health record software. Carbon — which has raised about $750 million in venture funding, including $100 million earlier this year — has been developing the AI-based health record software over the past few months and began using it on patients last month.

Hospitals 120

Hospitals 120

Pharmacy Times

JUNE 5, 2023

In data presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, amivantamab-vmjw plus lazertinib demonstrated promise as a first-line treatment for patients with advanced EGFR-mutated non-small cell lung cancer.

123

123

pharmaphorum

JUNE 5, 2023

ASCO: Moderna, Merck melanoma vaccine set for phase 3 Phil.

Vaccines 111

Vaccines 111

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JUNE 5, 2023

Rebyota is a live biotherapeutic product that is unfamiliar to many pharmacists and other health care providers with different steps in the eventual administration process.

122

122

Pharmaceutical Technology

JUNE 5, 2023

Earlier this year, Sun Pharmaceutical Industries , one of India’s largest generic drug producers, reported a major cybersecurity breach , impacting its business operations. A ransomware group later claimed responsibility for the incident, which was one of several high-profile cybersecurity breaches in India over the past three years. Pharma companies around the world have also faced similar threats , some of which have impacted national security and public health.

HIPAA 110

HIPAA Insurance Pharmaceutical Companies Pharmaceutical Companies 110

Fierce Healthcare

JUNE 5, 2023

Employee healthcare navigation company Transcarent has lined up its latest partnership, this time with digital health company ViewFi. | ViewFi is a virtual care platform built for orthopedic and musculoskeletal injuries and care. The company offers virtual healthcare, at-home exams and one-on-one appointments with orthopedic doctors and surgeons. Transcarent members will have access to some of the same orthopedic specialists that provide care to professional athletes.

110

110

STAT

JUNE 5, 2023

Ten years ago, clinicians in a handful of hospitals around the United States began sequencing the genomes of apparently healthy babies, seeking to understand how the technology might turn up hidden genetic disorders that aren’t being caught by routine newborn blood testing. New research from one such trial suggests the impact of having that kind of information extends far beyond the baby whose DNA is being decoded.

Hospitals 109

Hospitals 109

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

JUNE 5, 2023

Humana's primary care arm opened its 250th clinic in Dallas on Tuesday, marking another milestone in the insurer's growth in the provider space. | Humana's primary care arm opened its 250th clinic in Dallas on Tuesday, marking another milestone in the insurer's growth in the provider space.

Insurance 110

Insurance 110

STAT

JUNE 5, 2023

WASHINGTON — Ted Love has pretty much done everything there is to do in biotech. He’s worked for tiny startups and mega corporations. He sold his latest company to Pfizer for $5 billion amid an industry downturn. And now, he’s taking on a new challenge by becoming the chair of the board of the largest biotechnology lobby, BIO.

106

106

PharmExec

JUNE 5, 2023

Indicates that reimbursement for new slate of Alzheimer’s treatments will occur only with the completion of studies to support full approval.

105

105

Drug Store News

JUNE 5, 2023

According to a survey conducted by the National Retail Federation, consumers believe retail crimes have increased in their community.

105

105

STAT

JUNE 5, 2023

GLP-1s, a class of drugs including Ozempic and Wegovy that have become widely popular for treating obesity and diabetes, are also being studied for NASH , a form of fatty liver disease. But a new small study suggests GLP-1s may not dominate the disease area as they have others. Akero Therapeutics tested its experimental medicine efruxifermin in conjunction with a GLP-1, and found that patients taking the combination had reduced liver fat and improved markers of liver scarring compared with those

102

102

European Pharmaceutical Review

JUNE 5, 2023

Based on an in silico analysis of over 12,000 small molecule drugs and drug impurities , a recent paper has reported that the presence of nitrosamines in pharmaceuticals is likely more prevalent than originally expected. In total, 40.4 percent of the analysed active pharmaceutical ingredients (APIs) and 29.6 percent of the API impurities were revealed as potential nitrosamine precursors.

Packaging 98

Packaging 98

STAT

JUNE 5, 2023

A $203 million tax refund for Blue Cross Blue Shield of North Carolina. Nearly $1.5 billion in profit for Health Care Service Corp., the parent of five Blues plans. A quadrupling of profit at BCBS of Alabama. Publicly traded health insurers were not the only ones in the industry that continued to amass large windfalls in 2022. Many nonprofit and private Blue Cross Blue Shield companies ended last year with sizable gains that added to their mountainous cash reserves, according to a STAT analysis

Insurance 98

Insurance 98

European Pharmaceutical Review

JUNE 5, 2023

A two-year study monitoring microbial contamination of adipose tissue-derived stem cells (ADSC)-based advanced therapy medicinal products (ATMP) during manufacture , showed over 40 percent of lipoaspirate samples were contaminated with thirteen different microorganisms. over 40 percent of lipoaspirate samples [from ADSC-based ATMPs] were contaminated with thirteen different microorganisms” This is the first study to show this observation, according to the authors of the paper.

Documentation 98

Documentation 98

STAT

JUNE 5, 2023

This article is adapted from STAT’s latest report , Decoding Medicare: 10 key coverage decisions and how they’re made. F or years, patients and medical groups have advocated for Medicare to cover wheelchairs with power-seat elevation, allowing users to, among other things, reach cabinets and countertops more easily and conduct conversations eye to eye.

98

98

pharmaphorum

JUNE 5, 2023

ASCO: Vorasidenib shows its glioma potential in INDIGO Phil.

98

98

STAT

JUNE 5, 2023

In an important reminder that plugging digital tools into a clinical trial will not magically solve problems, Bellerophon Therapeutics announced Monday it would abandon a study of its treatment for pulmonary fibrosis after patients in a Phase 3 trial using a digital endpoint showed no improvement. Bellerophon’s study, which the New Jersey-based company boasted was the first pivotal trial to use a Food and Drug Administration-endorsed endpoint using wearable data, was closely watched by la

98

98

Drug Store News

JUNE 5, 2023

Dollar General reported a tough quarter as its core customers cut back on non-essential spending on discretionary goods.

98

98

Pharmaceutical Technology

JUNE 5, 2023

The Polish drug discovery and service provider Selvita has announced a new collaboration with the University of Oxford to advance the development of Parkinson’s disease therapies. Parkinson’s is caused by a build-up of alpha-synuclein, a small protein, forming aggregates inside vulnerable neurons. Cells are then unable to efficiently clear these aggregates, potentially killing neurons and allowing the disease to progress.

Communication 98

Communication 98

Drug Store News

JUNE 5, 2023

The Kegel Toner is a pelvic floor exerciser designed so users can regain control of their bladder and speed up postpartum recovery, the company said.

98

98

STAT

JUNE 5, 2023

CHICAGO — Yescarta, the CAR-T therapy made by the Kite unit of Gilead Sciences, prolonged the lives of patients with large B-cell lymphoma by 27% compared to standard treatment in a long-running clinical trial, researchers reported Monday. Proving a meaningful survival benefit for patients with a type of blood cancer represents another milestone for CAR-T therapy, which involves extracting white blood cells from a patient and genetically modifying them to attack cancer.

Chemotherapy 98

Chemotherapy 98